Table 1_Interobserver variability in organ delineation on radiotherapy treatment planning for nasopharyngeal carcinoma: A dosimetric and prognostic analysis.docx by Meining Chen (18693919)

“…Compared to standard delineations, all four physicians showed decreased TCPs (average decrease in ΔTCP >1%) and a significant increase in NTCPs of OARs. …”

PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

Table 1_Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.docx by Mohamed E. A. Mostafa (19834779)

“…ROSE-010 is linked to a greater incidence of nausea, vomiting, and headache than placebo.…”

Table 2_Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.xlsx by Mohamed E. A. Mostafa (19834779)

“…ROSE-010 is linked to a greater incidence of nausea, vomiting, and headache than placebo.…”

The effect of PCAIs on BRAF and RAF1 (CRAF) protein phosphorylation. by Matthew D. Gregory (19929096)

TRV-based silencing of <i>NbGAPCs</i> in <i>Nicotiana benthamiana</i> plants. by Yongle Zhang (11355546)

CTV p20 interacts with NbSGS3 and mediates autophagic degradation of NbSGS3. by Yongle Zhang (11355546)

Effects of activators and inhibitors on TcPiezo channels. by Guozhong Huang (673424)

“…Downregulation of <i>TcPiezo2</i> expression (+Tet) showed a significant decrease of lysosomal Ca²⁺ release as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1013105#ppat.1013105.g004" target="_blank">Fig 4A</a>. …”

Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

“…</p><p><b>Conclusion:</b> In 2021, ACM remained a significant global health burden, particularly affecting middle-aged and elderly populations with distinct demographic disparities. …”

TRV-based silencing of <i>NbATG5</i> and <i>NbATG7</i> in <i>Nicotiana benthamiana</i> plants. by Yongle Zhang (11355546)

The effect of PCAIs on MAPK pathway protein phosphorylation. by Matthew D. Gregory (19929096)

Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study by Emiko Otsuka (7519313)

“…Here, we retrospectively analyzed thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) levels in 51 patients (mean age: 72.3 ± 10.7 years; 58.8% male) undergoing hemodialysis before, during, and after halting roxadustat treatment. TSH levels were significantly decreased from a median of 2.46 (interquartile range:1.60–4.51) mU/L before roxadustat treatment to 1.36 (0.72–2.41) mU/L during treatment (<i>p</i> < 0.001), and improved to 2.56 (1.78–4.63) mU/L after halting roxadustat (<i>p</i> < 0.001). …”

MST1 upregulates CD36 expression via PPARγ. by Jianyang Li (461703)

Table 1_Effects of photoperiod on phytochemical profiles of four Ocimum basilicum genotypes in a hydroponic climate chamber.docx by Luana Pulvirenti (2925741)

“…Introduction<p>Ocimum basilicum L. (basil) is a widely used aromatic plant with recognized functional properties, largely attributed to its rich profile of bioactive secondary metabolites. …”

Table 2_Effects of photoperiod on phytochemical profiles of four Ocimum basilicum genotypes in a hydroponic climate chamber.docx by Luana Pulvirenti (2925741)

“…Introduction<p>Ocimum basilicum L. (basil) is a widely used aromatic plant with recognized functional properties, largely attributed to its rich profile of bioactive secondary metabolites. …”